Roche provides update on Phase III study of Tecentriq in people with muscle-invasive urothelial cancer MD bureau27 Jan 2020 2:22 PM ISTBasel: Roche has announced that the Phase III IMvigor010 study evaluating Tecentriq® (atezolizumab) as an adjuvant (after surgery) monotherapy...
USFDA completes inspection of Strides Pharma's Alathur facility with zero observations MD bureau26 Jan 2020 2:00 PM ISTNew Delhi: Drug firm Strides Pharma Science on Friday said the US health regulator has completed inspection of its Alathur facility in Tamil Nadu with...
Roche wins approval for cancer drug Kadcyla in China Medical Dialogues Bureau26 Jan 2020 10:15 AM ISTBeijing/Zurich: Roche said on Wednesday China had approved the import of its Kadcyla drug for breast cancer, another win for the Swiss drugmaker in...
DCGI releases list of Reference Products for conduct of BE Study, details Medical Dialogues Bureau25 Jan 2020 2:25 PM ISTNew Delhi: Through a recent notice, Drug Controller General of India has released the List of Products Permitted by DCG(I) and considered as Reference...
Kiran Mazumdar Shaw to be Executive Chairperson of Biocon for 5 years starting April 2020 MD bureau25 Jan 2020 2:14 PM ISTNew Delhi: The Board of Directors of Biocon Limited have approved the appointment of Kiran Mazumdar Shaw as Executive Chairperson of the Company for a...
Patanjali group eyes to be Rs 40,000-crore company in 2020-21 Medical Dialogues Bureau25 Jan 2020 12:24 PM ISTNew Delhi: Haridwar-based Patanjali group, which has acquired debt-ridden Ruchi Soya, expects to have a turnover of Rs 35,000-Rs 40,000 crore in the...
Sanofi Completes Acquisition of Synthorx Medical Dialogues Bureau25 Jan 2020 12:19 PM ISTPARIS- Sanofi has announced the successful completion of its acquisition of Synthorx, Inc. for $68 per share in cash. "The acquisition of...
Alembic Pharma gets final USFDA nod for Bosentan tablets to treat pulmonary arterial hypertension Medical Dialogues Bureau25 Jan 2020 12:11 PM ISTNew Delhi: Alembic Pharmaceuticals (Alembic) on Friday said it has received final nod from US health regulator for Bosentan tablets, used for...
Strides Pharma arm gets tentative USFDA nod for skin ointment Medical Dialogues Bureau25 Jan 2020 12:04 PM ISTNew Delhi: Strides Pharma Science on Friday said its arm has received tentative nod from US health regulator for triamcinolone acetonide ointment used...
Syngene International Limited announces Q3 FY20 results Medical Dialogues Bureau25 Jan 2020 11:00 AM ISTReports 11% revenue growth in Q3 to Rs. 539 Cr
Johnson & Johnson misses revenue estimates as blockbuster drugs disappoint Medical Dialogues Bureau24 Jan 2020 2:02 PM ISTUS: Johnson & Johnson narrowly missed quarterly revenue estimates on Wednesday as sales of its blockbuster psoriasis medicine Stelara and cancer...
Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome Medical Dialogues Bureau24 Jan 2020 11:31 AM ISTHod Hasharon: Wize Pharma a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it has...
